A severe oxaliplatin immune-induced syndrome after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC)

Abstract Objectives Oxaliplatin immune-induced syndrome (OIIS) was recently recognized as an uncommon complication of oxaliplatin therapy. Methods We report an exceptionally OIIS after pressurized intraperitoneal aerosol chemotherapy (PIPAC). Results Our patient developed a severe OIIS probably related to the intraperitoneal administration of oxaliplatin. Specific tests were performed and detected high-titer antibodies to oxaliplatin. Conclusions The OIIS is a rare. Physicians had to be aware of that clinical situation because it could be reversible, even in case of peritoneal advanced disease, and ICU treatment is justified.

[1]  C. Denlinger,et al.  Oxaliplatin-induced Immune Thrombocytopenia: A Case Report and Literature Review. , 2020, Clinical colorectal cancer.

[2]  J. Vyskočil,et al.  Type II hypersensitivity reactions after oxaliplatin rechallenge can be life threatening. , 2019, International immunopharmacology.

[3]  Y. Shibagaki,et al.  A case of biopsy-proven oxaliplatin-induced acute tubulointerstitial nephritis with thrombocytopenia and anemia , 2019, CEN Case Reports.

[4]  M. Pocard,et al.  Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design , 2018, Pleura and peritoneum.

[5]  J. Lacy,et al.  A patient with oxaliplatin immune-induced syndrome (OIIS) who also developed leucovorin and palonosetron-associated thrombocytopenia , 2018, Hematology.

[6]  K. Bencardino,et al.  Oxaliplatin Immune-Induced Syndrome Occurs With Cumulative Administration and Rechallenge: Single Institution Series and Systematic Review Study. , 2016, Clinical colorectal cancer.

[7]  S. Vesely,et al.  Drug-induced thrombotic microangiopathy: a systematic review of published reports. , 2015, Blood.

[8]  M. Mizuno,et al.  A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin , 2012, Clinical and Experimental Nephrology.

[9]  G. Garratty,et al.  Antibodies to oxaliplatin, a chemotherapeutic, are found in plasma of healthy blood donors , 2011, Transfusion.

[10]  I. Roberts,et al.  Management of Evans syndrome , 2006, British journal of haematology.

[11]  R. Meyboom,et al.  Drug-Induced Immune Thrombocytopenia , 2004, Drug safety.